
Professional with 12+ years of experience spanning portfolio strategy, competitive intelligence, computational biology and translational science in drug discovery. Specialised in synthesising complex biological, clinical and competitive landscapes into actionable insights that guide target prioritisation, asset evaluation and indication positioning. Experienced in supporting leadership decision-making across immunology, inflammation and cardio-metabolic therapeutic areas.